GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Cash Flow Reinvestment Rate
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs342.20 Million. See GlaxoSmithKline Pharmaceuticals Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline Pharmaceuticals Limited Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. For the full cash flow conversion analysis, see GLAXO cash generation efficiency.
Annual Cash Flow Reinvestment Rate for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year capital reinvestment analysis for GlaxoSmithKline Pharmaceuticals Limited. See GlaxoSmithKline Pharmaceuticals Limited financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | Rs688.30 Million | Rs12.90 Billion | Rs230.20 Million | ▼ -22.2% |
| 2024 | 0.07x | Rs399.33 Million | Rs5.82 Billion | Rs312.21 Million | ▼ -96.1% |
| 2023 | 1.76x | Rs8.52 Billion | Rs4.84 Billion | Rs440.40 Million | ▼ -22.8% |
| 2022 | 2.28x | Rs18.47 Billion | Rs8.11 Billion | Rs346.41 Million | ▲ +389.0% |
| 2021 | 0.47x | Rs2.69 Billion | Rs5.78 Billion | Rs442.27 Million | ▼ -7.8% |
| 2020 | 0.51x | Rs2.48 Billion | Rs4.90 Billion | Rs1.56 Billion | ▼ -35.2% |
| 2019 | 0.78x | Rs3.11 Billion | Rs3.99 Billion | Rs2.91 Billion | ▼ -49.9% |
| 2018 | 1.56x | Rs7.36 Billion | Rs4.73 Billion | Rs4.03 Billion | ▼ -52.7% |
| 2017 | 3.29x | Rs7.76 Billion | Rs2.36 Billion | Rs3.04 Billion | ▼ -42.7% |
| 2016 | 5.74x | Rs7.99 Billion | Rs1.39 Billion | Rs2.32 Billion | ▲ +494.3% |
| 2015 | 0.97x | Rs2.61 Billion | Rs2.70 Billion | Rs1.30 Billion | ▲ +160.0% |
| 2014 | 0.37x | Rs1.05 Billion | Rs2.81 Billion | Rs582.22 Million | ▲ +198.2% |
| 2013 | 0.12x | Rs390.76 Million | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs420.95 Million | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs213.94 Million | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs303.67 Million | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs238.79 Million | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs153.26 Million | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs186.23 Million | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs233.91 Million | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs93.72 Million | Rs2.29 Billion | Rs93.72 Million | — |